New chemotherapy regimens like ProMACE-MOPP offer improved survival rates for advanced non-Hodgkin's lymphomas. This research highlights significant complete remission and long-term disease-free survival, aiming to reduce treatment toxicity.
You might also read
Articles linked to this work by shared authors, journal, and citation graph.
Area of Science:
Background:
Purpose of the Study:
Main Methods:
Main Results:
Conclusions: